Biocon schedules a November 4, 2026 board meeting for Q2 FY27 unaudited results, plus an earnings call. Trading window stays closed until November 6, 2026.
Biocon Limited has scheduled a board meeting for May 7, 2026, to consider a proposal for fundraising via a preferential issue. The trading window for the company's securities remains closed from April 1, 2026, until May 9, 2026, as per insider trading regulations.